Retreatment with immune checkpoint inhibitors after a severe immune-related hepatitis: results from a prospective multicenter study - Riveiro-Barciela, M; Barreira-Díaz, A; Callejo-Pérez, A (Clin Gastroenterol Hepatol, 2023)